{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T20:34:57Z","timestamp":1786739697249,"version":"build-2736575974"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,11]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Duchenne Muscular Dystrophy (DMD) is an X-linked recessive muscular dystrophy that affects young boys and is caused by mutation of the dystrophin gene located over X chromosome.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>In this prospective study, 120 clinically diagnosed DMD patients were tested for exon deletions, duplication or point mutation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Of the 120 clinically suspected DMD patients, the diagnosis of DMD was confirmed by the genetic study or muscle biopsy in 116 patients. The mean age of onset was 3.2 years and the mean age at presentation was 7.2 years. 110\/120 cases were confirmed by genetic testing and six were by absence of staining for dystrophin on muscle biopsy. DMD gene deletion was present in 78.5%, duplication in 5.3% and point mutation in 11.2% cases. 70.3% of patients had deletion located at a distal hot spot region. Single exon deletion was found in 16.5%. Distal hotspot exons 47, 48 and 50 were the commonly deleted exons.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>In our study, 94.8% cases showed genetic change in the DMD gene. Muscle biopsy was the choice of investigation in earlier days. Detection of DMD by DNA based method eliminates the need to do an invasive procedure for diagnosis. Hence the genetic testing should be the investigation of choice in suspected cases of DMD. The pattern of deletion, obtained in the population of Rajasthan was similar when compared with other ethnic groups of the Indian population. It would be helpful for researchers to develop drugs specific to exons or for ongoing mutation-specific therapies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/aian.aian_126_21","type":"journal-article","created":{"date-parts":[[2021,8,19]],"date-time":"2021-08-19T08:49:10Z","timestamp":1629362950000},"page":"873-878","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["Duchenne Muscular Dystrophy"],"prefix":"10.4103","volume":"24","author":[{"given":"Manisha","family":"Goyal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashok","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamlesh","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seema","family":"Kapoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Somesh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-5-20240828","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1136\/bmj.317.7164.991","article-title":"The muscular dystrophies","volume":"317","author":"Emery","year":"1998","journal-title":"BMJ"},{"key":"R2-5-20240828","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/0092-8674(87)90579-4","article-title":"Dystrophin: The protein product of the Duchenne muscular dystrophy locus","volume":"51","author":"Hoffman","year":"1987","journal-title":"Cell"},{"key":"R3-5-20240828","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/ng0295-184","article-title":"The human dystrophin gene requires 16 h to be transcribed and is cotranscriptionally spliced","volume":"9","author":"Tennyson","year":"1995","journal-title":"Nat Genet"},{"key":"R4-5-20240828","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/hmg\/1.1.19","article-title":"Reconstruction of the 2.4 Mb human DMD-gene by homologous YAC recombination","volume":"1","author":"Den Dunnen","year":"1992","journal-title":"Hum Mol Genet"},{"key":"R5-5-20240828","first-page":"498","article-title":"The molecular basis for Duchenne versus Becker muscular dystrophy: Correlation of severity with type of deletion","volume":"45","author":"Koenig","year":"1989","journal-title":"Am J Hum Genet"},{"key":"R6-5-20240828","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/0092-8674(87)90504-6","article-title":"Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals","volume":"50","author":"Koenig","year":"1987","journal-title":"Cell"},{"key":"R7-5-20240828","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/329638a0","article-title":"Preferential deletion of exons in Duchenne and Becker muscular dystrophies","volume":"329","author":"Forrest","year":"1987","journal-title":"Nature"},{"key":"R8-5-20240828","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S1474-4422(09)70271-6","article-title":"Group DMDCCW. Diagnosis and management of Duchenne muscular dystrophy, part 1: Diagnosis, and pharmacological and psychosocial management","volume":"9","author":"Bushby","year":"2010","journal-title":"Lancet Neurol"},{"key":"R9-5-20240828","doi-asserted-by":"crossref","first-page":"310","DOI":"10.4103\/0028-3886.27164","article-title":"Analysis of dystrophin gene deletions by multiplex PCR in eastern India","volume":"54","author":"Basak","year":"2006","journal-title":"Neurol India"},{"key":"R10-5-20240828","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s13312-015-0660-8","article-title":"Genetic and clinical profile of patients of Duchenne muscular dystrophy: Experience from a tertiary care center in Eastern India","volume":"52","author":"Dey","year":"2015","journal-title":"Indian Pediatr"},{"key":"R11-5-20240828","first-page":"1","article-title":"Dystrophin gene deletions in South Indian Duchenne muscular dystrophy patients","volume":"57","author":"Mallikarjuna Rao","year":"2003","journal-title":"Indian J Med Sci"},{"key":"R12-5-20240828","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1007\/s004390050340","article-title":"Proportion and pattern of dystrophin gene deletion in North Indian Duchenne and Becker Muscular dystrophy patients","volume":"99","author":"Singh","year":"1997","journal-title":"Hum Genet"},{"key":"R13-5-20240828","doi-asserted-by":"crossref","first-page":"734","DOI":"10.4103\/0028-3886.59468","article-title":"Duchenne muscular dystrophy: A clinical, histopathological and genetic study at a neurology tertiary care center southern India","volume":"57","author":"Swaminathan","year":"2009","journal-title":"Neurol India"},{"key":"R14-5-20240828","doi-asserted-by":"crossref","first-page":"77","DOI":"10.4103\/0028-3886.222881","article-title":"Natural history of a cohort of Duchenne muscular dystrophy children seen between 1998 and 2014: An observational study from South India","volume":"66","author":"Singh","year":"2018","journal-title":"Neurol India"},{"key":"R15-5-20240828","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3988\/jcn.2017.13.1.91","article-title":"Duchenne muscular dystrophy and Becker muscular dystrophy confirmed by multiplex ligation-dependent probe amplification: Genotype-phenotype correlation in a large cohort","volume":"13","author":"Vengalil","year":"2017","journal-title":"J Clin Neurol"},{"key":"R16-5-20240828","doi-asserted-by":"crossref","first-page":"303","DOI":"10.4103\/0972-2327.138508","article-title":"Duchenne\/Becker muscular dystrophy: A report on clinical, biochemical, and genetic study in Gujarat population, India","volume":"17","author":"Rao","year":"2014","journal-title":"Ann Indian Acad Neurol"},{"key":"R17-5-20240828","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1471-2350-14-29","article-title":"MLPA-based genotype-phenotype analysis in 1053 Chinese patients with DMD\/BMD","volume":"14","author":"Yang","year":"2013","journal-title":"BMC Med Genet"},{"key":"R18-5-20240828","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1093\/qjmed\/hci113","article-title":"Analysis of an adult Duchenne muscular dystrophy population","volume":"98","author":"Parker","year":"2005","journal-title":"QJM"},{"key":"R19-5-20240828","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1007\/s00415-011-5979-z","article-title":"Genotype and phenotype characterization in a large dystrophinopathic cohort with extended follow-up","volume":"258","author":"Magri","year":"2011","journal-title":"J Neurol"},{"key":"R20-5-20240828","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000068446","article-title":"The heart in human dystrophinopathies","volume":"99","author":"Finsterer","year":"2003","journal-title":"Cardiology"},{"key":"R21-5-20240828","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/0960-8966(94)90073-6","article-title":"Mutation of dystrophin gene and cardiomyopathy","volume":"4","author":"Nigro","year":"1994","journal-title":"Neuromuscul Disord"},{"key":"R22-5-20240828","first-page":"117","article-title":"A report on higher frequency of DMD gene deletion in the Indian subcontinent","volume":"3","author":"Khalap","year":"1997","journal-title":"Indian J Hum Genet"},{"key":"R23-5-20240828","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/j.1442-200X.2008.02538.x","article-title":"Intragenic deletions in the dystrophin gene in 211 Pakistani Duchenne muscular dystrophy patients","volume":"50","author":"Hassan","year":"2008","journal-title":"Pediatr Int"},{"key":"R24-5-20240828","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1744-9081-4-20","article-title":"Similarity of DMD gene deletion and duplication in the Chinese patients compared to global populations","volume":"29","author":"Wang","year":"2008","journal-title":"Behav Brain Funct"},{"key":"R25-5-20240828","first-page":"145","article-title":"Patterns of dystrophin gene deletion in Egyptian Duchenne\/Becker muscular dystrophy patients","volume":"26","author":"El Sherif","year":"2007","journal-title":"Acta Myol"},{"key":"R26-5-20240828","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1002\/humu.20976","article-title":"Genotype-phenotype analysis in 2405 patients with dystrophinopathy using the UMD-DMD database: A model of nationwide knowledgebase","volume":"30","author":"Tuffery-Giraud","year":"2009","journal-title":"Hum Mutat"},{"key":"R27-5-20240828","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3233\/JND-200483","article-title":"Clinical phenotypes of DMD Exon 51 skip equivalent deletins: A systemic review","volume":"7","author":"Waldrop","year":"2020","journal-title":"J Neuromuscul Dis"},{"key":"R28-5-20240828","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1212\/WNL.0000000000002337","article-title":"Practice quideline update summary: Corticosteroid treatment of Duchenne muscular dystrophy: Report of quideline development subcommittee of the American Academy of Neurology","volume":"86","author":"Gloss","year":"2016","journal-title":"Neurology"},{"key":"R29-5-20240828","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.tips.2018.09.001","article-title":"Precision medicine through antisense oligonucleotide-mediated exon skipping","volume":"39","author":"Li","year":"2018","journal-title":"Trends Pharmacol Sci"},{"key":"R30-5-20240828","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1002\/humu.23561","article-title":"DMD genotype correlations from the Duchenne registry: Endogenous exon skipping is a factor in prolonged ambulation for individuals with a defined mutation subtype","volume":"39","author":"Wang","year":"2018","journal-title":"Hum Mutat"},{"key":"R31-5-20240828","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3390\/jpm10030111","article-title":"Advances in genetic characterization and genotype\u2013phenotype correlation of Duchenne and Becker muscular dystrophy in the personalized medicine","volume":"10","author":"Sheikh","year":"2020","journal-title":"J Pers Med"},{"key":"R32-5-20240828","first-page":"25","article-title":"Pharmacotherapy of Duchenne muscular dystrophy","volume":"2261","author":"Hoffman","year":"2020","journal-title":"Handb Exp Pharmacol"},{"key":"R33-5-20240828","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1089\/nat.2018.0756","article-title":"A sequel to the Eteplirsen Saga: Eteplirsen is approved in the United States but was not approved in Europe","volume":"29","author":"Aartsma-Rus","year":"2019","journal-title":"Nucleic Acid Ther"},{"key":"R35-5-20240828","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1007\/s40265-020-01339-3","article-title":"Viltolarsen: First Approval","volume":"80","author":"Dhillon","year":"2020","journal-title":"Drugs"}],"container-title":["Annals of Indian Academy of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/aian.AIAN_126_21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T19:31:28Z","timestamp":1786735888000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/aian.AIAN_126_21"}},"subtitle":["Genetic and Clinical Profile in the Population of Rajasthan, India"],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.4103\/aian.aian_126_21","relation":{},"ISSN":["0972-2327"],"issn-type":[{"value":"0972-2327","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]}}}